Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse

Hierarchical Grouping to Optimize an Objective Function

1963 • 17,257 citations

Hierarchical Grouping to Optimize an Objective Function

1963 • 3,111 citations

Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities

2008 • 814 citations

Mechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based Populations

2007 • 329 citations

Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems

1993 • 272 citations

Abuse Liability of Flunitrazepam

1997 • 255 citations

Buprenorphine-Related Deaths Among Drug Addicts in France: A Report on 20 Fatalities

1998 • 214 citations

Principles of laboratory assessment of drug abuse liability and implications for clinical development

2009 • 196 citations

Principles of initial experimental drug abuse liability assessment in humans

2003 • 186 citations

Analytic models to identify patients at risk for prescription opioid abuse.

2009 • 172 citations

Guidelines and methodological reviews concerning drug abuse liability assessment

2003 • 164 citations

Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006

2009 • 152 citations

The Development of a Comprehensive Risk-Management Program for Prescription Opioid Analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS^®)

2007 • 139 citations

Seeking drugs or seeking help? Escalating “doctor shopping” by young heroin users before fatal overdose

2004 • 136 citations

Pharmacoepidemiological research using French reimbursement databases: yes we can!

2010 • 134 citations

Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic

1999 • 116 citations

Impact of a prescription monitoring program on doctor‐shopping for high dosage buprenorphine

2008 • 116 citations

Buprenorphine prescription by general practitioners in a French region

2002 • 93 citations

National addictions vigilance intervention and prevention program (NAVIPPRO™): a real‐time, product‐specific, public health surveillance system for monitoring prescription drug abuse

2008 • 93 citations

Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence

2008 • 92 citations

Assessment of Abuse Potential of Benzodiazepines from a Prescription Database Using ‘Doctor Shopping’ as an Indicator

2010 • 90 citations

Assessment of doctor‐shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database

2003 • 87 citations

Co-abuse of opiates and benzodiazepines

1999 • 72 citations

Survey of Forged Prescriptions to Investigate Risk of Psychoactive Medications Abuse in France

2007 • 72 citations

Monitoring risk: Post marketing surveillance and signal detection

2009 • 65 citations

Carisoprodol use and abuse in Norway. A pharmacoepidemiological study

2007 • 61 citations

Study on doctor shopping behavior: Insight from patients with upper respiratory tract infection in Taiwan

2009 • 61 citations

Observation of Psychoactive Substance Consumption: Methods and Results of the French OPPIDUM Programme

2001 • 56 citations

Assessing abuse liability in clinical trials

2003 • 50 citations

ABC of mental health: Addiction and dependence I: Illicit drugs

1997 • 49 citations

Postmarketing surveillance for drug abuse

2003 • 40 citations

Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007

2009 • 35 citations

Abus d’alcool et de benzodiazépines lors des traitements de substitution chez l’héroïnomane : une revue de la littérature

2008 • 34 citations

Détournement d’usage du trihexyphénidyle (Artane®, Parkinane®) : tendances récentes

2003 • 34 citations

Utilisation des bases de données de l’Assurance Maladie par les Centres d’Evaluation et d’Information sur la Pharmacodépendance : exemples, intérêts et perspectives

2004 • 34 citations

Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users

2003 • 30 citations

Signal detection in post-marketing surveillance for controlled substances

2009 • 28 citations

Estimation of clonazepam abuse liability: a new method using a reimbursed drug database

2009 • 26 citations

Détournement d’usage du clonazépam (Rivotril®) : tendances récentes

2006 • 21 citations

Abus et dépendances aux produits psychoactifs : étude de consommations à travers l’enquête OPPIDUM 2004 du réseau des CEIP

2007 • 20 citations